Xcout Intel
ImmunityBio
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
Subscribe to see ImmunityBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ImmunityBio at a glance
ImmunityBio is a biotech company headquartered in United States. It has raised at least $499.1M across the 3 funding rounds on record. Its most recent funding round, Growth, raised $470M in September 2023. Xcout tracks 11 named people at ImmunityBio, including Patrick Soon-Shiong (CEO). Xcout recorded 3 job postings from ImmunityBio in the last 90 days.
ImmunityBio leadership
- Patrick Soon-ShiongCEO
- Rich AdcockPresident & Chief Executive Officer
- David SachsChief Financial Officer
- Leonard S. Sender, M.D.Chief Medical Officer, Liquid Tumors & Cell Therapy
- Patrick Soon-Shiong, M.D.Executive Chairman and Global Chief Scientific and Medical Officer, ImmunityBio
- Dr. Jim Yong KimVice Chairman
5 more named people on record for ImmunityBio, with roles, board committees and tenure — see the full roster →
ImmunityBio funding rounds
At least $499.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $470M | 2 named | |
| SEC Form D filing | $10.7M | — | |
| Series B | $18.4M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at ImmunityBio
Xcout recorded 3 job postings from ImmunityBio in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see ImmunityBio's hiring signals →
Investors
ImmunityBio competitors
A few of ImmunityBio's closest competitors — see the full list of competitors and alternatives →
IO Biotech, Inc. is a clinical-stage biopharmaceutical company that develops novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines. Its proprietary T-win® technology is designed to modulate the tumor microenvironment by targeting both tumor cells and immune-suppressive cells, aiming to improve treatment outcomes for patients with melanoma and other tumor types.
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
GlobeImmune, Inc. is a clinical-stage biopharmaceutical company headquartered in Louisville, Colorado, focused on developing therapeutic vaccines to treat cancer and infectious diseases.
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Get ImmunityBio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ImmunityBio in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access